SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of TG Therapeutics, Inc. - TGTX PR Newswire NEW YORK, Sept. 13, 2023 NEW YORK , Sept. 13, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of TG Therapeutics, Inc. ("TG Therapeutics" or the "Company") (NASDAQ: TGTX). Such investors are advised to contact Robert S. Willoughby at
[email protected] or 888-476-6529, ext. 7980. The investigation concerns whether TG Therapeutics and...